Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

Rhea-AI Summary

Pulmonx, a leader in minimally invasive lung disease treatments, will release its Q2 2024 financial results on July 31, 2024. The announcement will be made post-market close, and a conference call will follow at 1:30 p.m. PT / 4:30 p.m. ET. Investors can access both live and archived webcasts on Pulmonx's investor relations website.

Positive

• Announcement of Q2 2024 financial results release date showing transparency and regular communication.
• Hosting a conference call for analysts and investors indicates proactive investor relations.

Negative

• None.

REDWOOD CITY, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2024 after the close of trading on Wednesday, July 31, 2024. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET.

A live and archived webcast of the event will be available on the “Investors” section of the Pulmonx website at https://investors.pulmonx.com/.

About Pulmonx Corporation
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx’s Zephyr^® Endobronchial Valve, Chartis^® Pulmonary Assessment System and StratX^® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option for improving breathing, activity and quality of life in patients with severe emphysema. For more information on the Zephyr Valves and the company, please visit www.Pulmonx.com.

Contact
Brian Johnston
Gilmartin Group
investors@pulmonx.com

FAQ

When will Pulmonx announce its Q2 2024 financial results?

Pulmonx will release its Q2 2024 financial results on July 31, 2024, after market close.

What time is the Pulmonx Q2 2024 financial results conference call?

The Pulmonx Q2 2024 financial results conference call will begin at 1:30 p.m. PT / 4:30 p.m. ET on July 31, 2024.

How can I access Pulmonx's Q2 2024 financial results webcast?

You can access the live and archived webcast of Pulmonx's Q2 2024 financial results on their investor relations website at https://investors.pulmonx.com/.

What is Pulmonx's stock symbol?

Pulmonx's stock symbol is LUNG.